Implications of Genomic and Genetic Testing for the Management of Prostate Cancer Patients | OncologyPRO
ESMO E-Learning: Implications of Genomic and Genetic Testing for the Management of Prostate Cancer Patients
ESMO E-Learning: Implications of Genomic and Genetic Testing for the Management of Prostate Cancer Patients
Real World Data and Digital Oncology – Digital Health as Cancer Care Facilitator: the Power of a Standardised European Health Record 2024Chairs: Anna Pellat, Carola…
OncologyPRO is the home of ESMO’s educational & scientific resources, with exclusive content for ESMO members such as ESMO’s Congresses webcasts,
Following the Ombudsman’s recent findings of maladministration regarding the Commission’s interactions with tobacco lobbyists
Application deadline: 31 May 2024 (12:00 CEST)
Clinical trials have an impact on the environment, and novel approaches may help researchers reshape their activities toward a greater sustainability
The abstract submission system is now open
Merkel-cell carcinoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.